Financial insights of EVH

MyFinsight

For the year ending 2025-12-31, EVH made $1,876,229K in revenue. -$579,401K in net income. Net profit margin of -30.88%.

Income Statement	2025-12-31
Revenue	1,876,229
Cost of revenue	1,476,346
Selling, general and administrative expenses	303,866
Depreciation and amortization expenses	115,851
Loss on lease termination	-676
(gain) loss on disposal of non-strategic assets	14,867
Right-of-use asset impairment	0
Goodwill impairment	398,000
Change in fair value of contingent consideration	6,495
Operating expenses	2,286,367
Operating loss	-410,138
Interest income	4,190
Interest expense	57,471
Gain (loss) from equity method investees	365
Loss on extinguishment/repayment of debt	-3,483
Loss on option exercise	-52,544
Extinguishment of series a preferred stock and other refinancing fees	15,000
Change in tax receivables agreement liability	-804
Other expense, net	249
Loss before income taxes	-534,636
Benefit from income taxes	-126
Income (loss) before preferred dividends and accretion of series a preferred stock	-534,510
Dividends and accretion of series a preferred stock including excise tax	44,891
Net loss attributable to common shareholders of evolent health, inc. - diluted	-579,401

Basic EPS	-5.07
Diluted EPS	-5.07
Basic Average Shares	114,208,000
Diluted Average Shares	114,208,000